AI in Pathology Market worth $347.4 million by 2030
The report "AI in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030", is projected to reach USD 347.4 million by 2030, up from USD 107.4 million in 2025, at a CAGR of 26.5 % during the forecast period.
Browse 272 market data Tables and 51 Figures spread through 319 Pages and in-depth TOC on "AI in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical Workflow), End User (Hospitals, Labs, Pharma/Biotech), & Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ai-in-pathology-market-86647266.html
Factors such as the development of CNNS and advanced AI models, increasing cases of misdiagnoses in patients, benefits of AI-augmented telepathology, and the increasing adoption of whole slide imaging analysis (WSI) in digital pathology are driving market growth. Enhancements in computational pathology, growing use of cloud-based AI pathology platforms, and mounted adoption of multi-omics platforms are accelerating market growth.
The drug discovery segment accounted for the largest share of the AI in pathology market in 2024, by use case.
In 2024, the drug discovery segment accounted for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. The increasing pharmaceutical & biotechnology R&D expenditure, the growth in high-throughput screening & imaging, the rising use of AI algorithms in pathology image analysis for the identification & classification of diseases, and the ability of AI to accelerate the development of new therapeutics are expected to contribute to market growth.
By function, the image analysis segment accounted for the largest share in 2024 of the AI in pathology market.
In 2024, the image analysis segment accounted for the largest share of the AI in pathology market. The large share of the image analysis segment is attributed to the increasing demand for early diagnosis & precision capabilities, the integration of digital pathology, the shortage of skilled pathologists, and the increased demand for personalized and targeted therapies.
By region, Europe led with the second-largest share of the AI in pathology market in 2024.
Europe held the second-largest share of the AI in pathology market in 2024. The primary factors of market growth include the rising adoption of AI-based tools in pathology research and drug discovery, favorable government initiatives, increasing patient data volume, increasing venture capital funding, rising healthcare expenditure, and the growing geriatric population. The presence of key AI product & service providers for pathology applications in the region is complementing the growth of this market.
The report profiles key players such as Koninklijke Philips N.V. (Netherlands), F. www Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc. (US), Akoya Biosciences, Inc. (US), Aiforia Technologies Plc (Finland), Indica Labs Inc. (US), OptraScan (US), Ibex Medical Analytics Ltd. (Israel), Mindpeak GmbH (Germany), Tribun Health (France).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the AI in Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
